350 related articles for article (PubMed ID: 33951889)
21. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
[TBL] [Abstract][Full Text] [Related]
22. Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.
Frontzek F; Staiger AM; Zapukhlyak M; Xu W; Bonzheim I; Borgmann V; Sander P; Baptista MJ; Heming JN; Berning P; Wullenkord R; Erdmann T; Lutz M; Veratti P; Ehrenfeld S; Wienand K; Horn H; Goodlad JR; Wilson MR; Anagnostopoulos I; Lamping M; Gonzalez-Barca E; Climent F; Salar A; Castellvi J; Abrisqueta P; Menarguez J; Aldamiz T; Richter J; Klapper W; Tzankov A; Dirnhofer S; Rosenwald A; Mate JL; Tapia G; Lenz P; Miething C; Hartmann W; Chapuy B; Fend F; Ott G; Navarro JT; Grau M; Lenz G
Nat Commun; 2021 Aug; 12(1):5183. PubMed ID: 34465776
[TBL] [Abstract][Full Text] [Related]
23. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy.
Ogiyama H; Murayama Y; Tsutsui S; Iwasaki T; Kuriyama D; Horiki M; Imanaka K; Kimura H; Inoue M; Iishi H
Clin J Gastroenterol; 2023 Apr; 16(2):198-205. PubMed ID: 36609818
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.
Zhou T; Cheng J; Karrs J; Davies-Hill T; Pack SD; Xi L; Tyagi M; Kim J; Jaffe ES; Raffeld M; Pittaluga S
Am J Surg Pathol; 2022 Oct; 46(10):1364-1379. PubMed ID: 35650679
[TBL] [Abstract][Full Text] [Related]
25. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.
Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A
Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007
[TBL] [Abstract][Full Text] [Related]
26. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
[TBL] [Abstract][Full Text] [Related]
27. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly.
Gebauer N; Gebauer J; Hardel TT; Bernard V; Biersack H; Lehnert H; Rades D; Feller AC; Thorns C
Leuk Lymphoma; 2015 Apr; 56(4):1100-6. PubMed ID: 25030036
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of EBV associated diffuse large B-cell lymphoma.
Frontzek F; Staiger AM; Wullenkord R; Grau M; Zapukhlyak M; Kurz KS; Horn H; Erdmann T; Fend F; Richter J; Klapper W; Lenz P; Hailfinger S; Tasidou A; Trautmann M; Hartmann W; Rosenwald A; Quintanilla-Martinez L; Ott G; Anagnostopoulos I; Lenz G
Leukemia; 2023 Mar; 37(3):670-679. PubMed ID: 36604606
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
[TBL] [Abstract][Full Text] [Related]
32. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
Shwe S; Sharma AA; Lee BA; Smith JE
Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
35. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
36. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
[TBL] [Abstract][Full Text] [Related]
37. Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer.
Bricman L; Yengue P; Miscu C; Junius S; Waignein F; Vandenbulcke JM
Acta Gastroenterol Belg; 2021; 84(4):663-665. PubMed ID: 34965049
[TBL] [Abstract][Full Text] [Related]
38. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
[TBL] [Abstract][Full Text] [Related]
39. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
[TBL] [Abstract][Full Text] [Related]
40. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.
Lorenzi L; Lonardi S; Essatari MH; Pellegrini V; Fisogni S; Gazzola A; Agostinelli C; Vermi W; Rossi G; Massarelli G; Pileri SA; Facchetti F
Virchows Arch; 2016 Apr; 468(4):441-50. PubMed ID: 26762526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]